γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-483
Published Online: 2014-07-04
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rawlinson, Rebecca
Massey, Andrew J
License valid from 2014-07-04